Cargando…
Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
BACKGROUND: Cuproptosis, a unique kind of cell death, has implications for cancer therapy, particularly lung adenocarcinoma (LUAD). Long non-coding RNAs (lncRNAs) have been demonstrated to influence cancer cell activity by binding to a wide variety of targets, including DNA, RNA, and proteins. METHO...
Autores principales: | Zhang, Pengpeng, Pei, Shengbin, Liu, Jianlan, Zhang, Xiao, Feng, Yanlong, Gong, Zeitian, Zeng, Tianyu, Li, Jun, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887198/ https://www.ncbi.nlm.nih.gov/pubmed/36733364 http://dx.doi.org/10.3389/fonc.2022.1088931 |
Ejemplares similares
-
Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022) -
A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023) -
A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023) -
By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023) -
A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)